Healthcare provider profile · identity verified

Javid Akram, MD

Internal Medicine · MAPLEWOOD, MN · NPI 1992734396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	892	256
Amlodipine Besylate	Amlodipine Besylate	492	145
Losartan Potassium	Losartan Potassium	432	120
Lisinopril	Lisinopril	406	121
Omeprazole	Omeprazole	400	107
Metoprolol Succinate	Metoprolol Succinate	342	102
Levothyroxine Sodium	Levothyroxine Sodium	338	101
Tamsulosin Hcl	Tamsulosin Hcl	308	93
Rosuvastatin Calcium	Rosuvastatin Calcium	283	99
Metformin Hcl Er	Metformin Hcl	260	73
Gabapentin	Gabapentin	253	79
Metformin Hcl	Metformin Hcl	247	68
Simvastatin	Simvastatin	227	63
Hydrochlorothiazide	Hydrochlorothiazide	203	58
Pravastatin Sodium	Pravastatin Sodium	198	63
Pantoprazole Sodium	Pantoprazole Sodium	190	58
Furosemide	Furosemide	179	56
Trazodone Hcl	Trazodone Hcl	165	50
Warfarin Sodium	Warfarin Sodium	163	31
Glipizide	Glipizide	156	48
Albuterol Sulfate Hfa	Albuterol Sulfate	145	67
Famotidine	Famotidine	145	49
Metoprolol Tartrate	Metoprolol Tartrate	134	45
Allopurinol	Allopurinol	130	37
Sertraline Hcl	Sertraline Hcl	127	42
Fluticasone Propionate	Fluticasone Propionate	123	56
Eliquis	Apixaban	106	32
Jardiance	Empagliflozin	103	21
Atenolol	Atenolol	94	28
Azithromycin	Azithromycin	94	85
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	30
Nystatin	Nystatin	91	47
Escitalopram Oxalate	Escitalopram Oxalate	89	30
Fluoxetine Hcl	Fluoxetine Hcl	76	19
Mirtazapine	Mirtazapine	76	24
Alendronate Sodium	Alendronate Sodium	74	20
Duloxetine Hcl	Duloxetine Hcl	67	15
Potassium Chloride	Potassium Chloride	66	17
Meloxicam	Meloxicam	65	27
Citalopram Hbr	Citalopram Hydrobromide	64	19
Clopidogrel	Clopidogrel Bisulfate	62	21
Prednisone	Prednisone	57	50
Xarelto	Rivaroxaban	55	12
Finasteride	Finasteride	54	13
Hydralazine Hcl	Hydralazine Hcl	54	18
Hydroxyzine Hcl	Hydroxyzine Hcl	51	18
Tizanidine Hcl	Tizanidine Hcl	51	20
Doxycycline Monohydrate	Doxycycline Monohydrate	50	39
Bupropion Xl	Bupropion Hcl	49	16
Ozempic	Semaglutide	49	12
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	44	25
Spironolactone	Spironolactone	43	12
Tramadol Hcl	Tramadol Hcl	43	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	15
Glipizide Er	Glipizide	42	11
Trulicity	Dulaglutide	42	suppressed
Hydrocortisone	Hydrocortisone	38	17
Meclizine Hcl	Meclizine Hcl	38	15
Diclofenac Sodium	Diclofenac Sodium	36	12
Ezetimibe	Ezetimibe	36	12
Ketoconazole	Ketoconazole	36	16
Levetiracetam	Levetiracetam	36	suppressed
Olanzapine	Olanzapine	36	suppressed
Glimepiride	Glimepiride	35	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	13
Carvedilol	Carvedilol	34	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	12
Cephalexin	Cephalexin	31	25
Januvia	Sitagliptin Phosphate	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	11
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Estradiol	Estradiol	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Mounjaro	Tirzepatide	28	suppressed
Nitroglycerin	Nitroglycerin	27	19
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	17
Montelukast Sodium	Montelukast Sodium	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Atovaquone-Proguanil Hcl	Atovaquone/Proguanil Hcl	25	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Risperidone	Risperidone	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Baclofen	Baclofen	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin	Amoxicillin	16	14
Divalproex Sodium	Divalproex Sodium	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Novolog Flexpen	Insulin Aspart	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error